Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: epirubicin|DRUG: vinorelbine
Sponsor: University of Medicine and Dentistry of New Jersey
Collaborators: National Cancer Institute (NCI)